This high-strength combination of Glimepiride 2 mg and sustained-release Metformin Hydrochloride 1000 mg is formulated for patients requiring more intensive oral antidiabetic therapy under medical supervision.

Each unit of this high-dose antidiabetic combination tablet contains Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000 mg (sustained release), formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating type 2 diabetes intensive therapy medication for their regional markets.

Used in the management of type 2 diabetes mellitus in patients requiring higher-dose combination therapy. Distributed to pharmacies, hospitals, and diabetes management centers.

Packed in 10x10 blister strips suitable for bulk export shipment and extended storage. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing sulfonylurea biguanide combination formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying high-dose antidiabetic combination tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte?
A: It contains Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000 mg (sustained release), manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte?
A: Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte is manufactured and supplied by CD&M Remedies, under product code 1007.

Q: Which product category does Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte belong to?
A: It falls under the Anti-Diabetic Combination Medication category, intended for B2B pharmaceutical buyers and importers.